Singular Genomics Systems

Medtech

singulargenomics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
40
13 granted · 27 pending
Sector median: 2

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2147ISS, INC.——
2148IVSONANCE BIOMEDICAL INC——
2149MEMStim LLC——
2150Singular Genomics Systems——
2151Eysz, Inc.——
2152NEXTILES INC——
2153CANAIRY LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 13 granted of 40
  • Methods And Devices For Manipulating Biological Samplesapplication
  • Detection Of Analytes In Cells And Tissuesapplication
  • Silicon Containing Modified Nucleotide Analogsapplication
  • Template Arraygranted
  • Wash Bottlegranted
  • Imaging Systems And Methods Useful For Patterned Structuresapplication
  • Devices For Mating Glass Slidesapplication
  • Slide Bonding Apparatusapplication
  • Pusher Transfer Toolgranted
  • Kits For Nucleic Acid Sequencing Using Modified Archaeal Family B Polymerasesapplication
  • Methods And Devices For Tissue Sample Manipulationapplication
  • Methods, Compositions, And Solid Supports For Multi-dimensional Sequencinggranted

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.